The RSUs vest over four years, with 25% of the underlying shares vesting on each of the four anniversaries of the applicable vesting commencement date, subject to the new employee's continued service relationship with Revance through the applicable vesting dates.
The Compensation Committee of Revance's Board of Directors approved the awards as an inducement material to the new employees' employment in accordance with NASDAQ Listing Rule 5635(4).
About Revance
Revance is a biotechnology company setting the new standard in healthcare with innovative aesthetic and therapeutic offerings that enhance patient outcomes and physician experiences. Revance's portfolio includes DAXXIFY (DaxibotulinumtoxinA-lanm) for injection and the RHA Collection of dermal fillers in the
Revance's global headquarters and experience center is located in
'Revance', the Revance logo, and DAXXIFY are registered trademarks of
Contact:
Tel: 510-279-6886
Email: jessica.serra@revance.com
(C) 2024 Electronic News Publishing, source